EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8

Rong Jin, Miaoni Zhou, Fuquan Lin iD, Wen Xu, Aie Xu

Cells · 2023

DOI: 10.3390/cells12020217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Rong Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou 310009, China. Hauptthemen laut MEDLINE: Vitiligo, Janus Kinase Inhibitors. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Joint Fund Project, National Natural Science Foundation of China, Zhejiang Science and Technology Plan of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Vitiligo is a T cell-mediated skin depigmentation disease. Though treatments arresting disease progression and inducing repigmentation are available, the efficacy of these options is often limited and poorly sustained. How stromal signals contribute to the interferon-γ-dominant skin niches is unclear. This study aims to determine how fibroblasts participate in the IFN-γ-dominant vitiligo niche. Patients and methods: Mouse vitiligo models were established. Fibroblasts from control and vitiligo mice were extracted for RNA sequencing. In vitro IFN-γ stimulation was performed to verify the JAK-STAT pathway by qPCR and Western blot. T cell polarization with chemokines was measured by flow cytometry. Protein levels in tissues were also examined by IHC.

Results

The vitiligo mouse model recapitulates the human CD8-IFN-γ pathway. RNA sequencing revealed elevated chemokine CCL2 and CCL8 in vitiligo fibroblast, which may be regulated by the JAK-STAT signaling. Such phenomenon is verified by JAK inhibitor peficitinib in vitro. Moreover, CCL2 addition into the naïve T polarization system promoted type 2 cytokines secretion, which represents a hallmark of vitiligo lesions.

Conclusion

Dermal fibroblasts, a principal constituent of skin structure, respond to IFN-γ by skewing T cells towards a type 2 cytokine profile via CCL2 and CCL8, which can be abrogated by JAK inhibitor peficitinib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoJanus Kinase InhibitorsHumansMiceAnimalsInterferon-gammaJanus KinasesSignal TransductionSTAT Transcription FactorsFibroblastsChemokine CCL8Chemokine CCL2AdamantaneNiacinamide

Stichwörter der Autor:innen

CCL2JAKT cellsfibroblastvitiligo

Substanzen

Interferon-gammaJanus Kinase InhibitorsJanus KinasesSTAT Transcription FactorsChemokine CCL8Chemokine CCL2peficitinibAdamantaneNiacinamideCCL8 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou 310009, China.

ORCID-Profile: Fuquan Lin

Förderung

  • National Natural Science Foundation of China Joint Fund Project
  • National Natural Science Foundation of China
  • Zhejiang Science and Technology Plan of Traditional Chinese Medicine
  • Hangzhou Medical and Health Science and Technology Project

Zitieren

APA

Jin, R., Zhou, M., Lin, F., Xu, W., & Xu, A. (2023). Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8. Cells. https://doi.org/10.3390/cells12020217

Vancouver

Jin R, Zhou M, Lin F, Xu W, Xu A. Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8. Cells. 2023. doi:10.3390/cells12020217

BibTeX
@article{Jin2023,
  author = {Jin, Rong and Zhou, Miaoni and Lin, Fuquan and Xu, Wen and Xu, Aie},
  title = {Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12020217}
}
Kostenlos starten →